Overview
Cefuroxime is a highly versatile, second-generation cephalosporin antibiotic. It offers a broader spectrum of antibacterial activity compared to first-generation cephalosporins, making it particularly effective against certain strains of bacteria that produce beta-lactamase. It is frequently prescribed as a reliable alternative for treating respiratory tract infections, ear infections, and urinary tract infections.

Mechanism of Action
Cefuroxime exerts its bactericidal effect by targeting the bacterial cell wall. It binds to essential penicillin-binding proteins (PBPs) located within the bacterial cell membrane. This action severely disrupts the cross-linking process necessary for the structural integrity of the peptidoglycan layer, causing the cell wall to weaken, rupture, and ultimately leading to the death of the bacteria.

Dosage and Administration
For adults, the typical oral dosage for most mild to moderate infections ranges from 250 mg to 500 mg taken twice daily for a duration of 7 to 10 days. To maximize absorption and enhance its bioavailability, it is strongly recommended that oral cefuroxime be taken shortly after a meal.

Side Effects
The medication is generally well-tolerated by most patients. The most commonly reported adverse effects are mild gastrointestinal disturbances, such as diarrhea, nausea, and occasional abdominal pain. In rare instances, it can cause an overgrowth of Clostridium difficile, leading to severe, persistent diarrhea that requires immediate medical attention.

Contraindications and Precautions
Cefuroxime is contraindicated in individuals with a known severe hypersensitivity or anaphylactic reaction to cephalosporins. Because there is a known cross-reactivity rate between penicillins and cephalosporins, it should be administered with extreme caution to patients who have a documented history of severe penicillin allergies.

Pregnancy and Lactation
Cefuroxime is widely considered safe for use during pregnancy and is often utilized when clinically necessary. It is excreted into human breast milk in very small quantities. While generally considered compatible with breastfeeding, the nursing infant should be observed for potential signs of altered bowel flora, such as diarrhea.